Dr. Hans Jörg Reinhardt is an Independent Non-Executive Director at Swiss Re AG, an Independent Non-Executive Chairman at Novartis AG, a Council Member at International Federation of Pharmaceutical Manufacturers, a Chairman at Novartis Foundation, a Chairman at Novartis Institutes for Biomedical Research, Inc., a Chairman at Novartis, Inc. and a Chairman-Supervisory Board at Novartis International AG.
He is on the Board of Directors at Swiss Re AG and The Genomics Institute of the Novartis Research Foundation. Dr. Reinhardt was previously employed as a Chairman-Management Board by Bayer HealthCare AG, a Chief Operating Officer by Novartis AG, a Member-Supervisory Board by MorphoSys AG, a Chairman by The Genomics Institute of the Novartis Research Foundation, and a Head-Development by Sandoz Pharmaceuticals AG.
He also served on the board at Lonza Group AG.
He received his doctorate degree from Universität des Saarlandes.